Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

Embolic protection devices are essential instruments during such operations since they play a crucial role in reducing these hazards. The market for embolic protection devices is growing in both ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

Embolic protection devices are specialized medical instruments designed to capture and remove embolic debris that may be dislodged during vascular or cardiovascular procedures. These devices help ...

LONDON — Two years after the large multinational PROTECTED TAVR trial failed to associate a cerebral embolic protection (CEP) device with significant protection from stroke in patients undergoing ...

It’s easy to see why observers are confused by PROTECTED TAVR. Since the cerebral embolic protection (CEP) results were released at TCT 2022, there have been conflicting messages as to just how much ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

The recall was initiated following reports of 9 device malfunctions. Cardiovascular Systems Inc. has issued a voluntary recall of unused WIRION ® Embolic Protection systems due to complaints of filter ...

(RTTNews) - Cardiovascular Systems Inc. (CSII) has initiated a voluntary recall of unused WIRION Embolic Protection Systems due to complaints of filter breakage during retrieval. The company said it ...

United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...